Barbara Zellinger

441 total citations
18 papers, 333 citations indexed

About

Barbara Zellinger is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Barbara Zellinger has authored 18 papers receiving a total of 333 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Pulmonary and Respiratory Medicine and 5 papers in Genetics. Recurrent topics in Barbara Zellinger's work include Glioma Diagnosis and Treatment (5 papers), Lung Cancer Diagnosis and Treatment (5 papers) and MicroRNA in disease regulation (4 papers). Barbara Zellinger is often cited by papers focused on Glioma Diagnosis and Treatment (5 papers), Lung Cancer Diagnosis and Treatment (5 papers) and MicroRNA in disease regulation (4 papers). Barbara Zellinger collaborates with scholars based in Austria and Germany. Barbara Zellinger's co-authors include Karel Říha, Svetlana Akimcheva, Jasna Puizina, Branislav Kusenda, Felix Sedlmayer, Franz Zehentmayr, Karl Sotlar, Gerd Fastner, Roland Reitsamer and Theo F. J. Kraus and has published in prestigious journals such as Genes & Development, SHILAP Revista de lepidopterología and Molecular Cell.

In The Last Decade

Barbara Zellinger

18 papers receiving 330 citations

Peers

Barbara Zellinger
Judit Pampalona Spain
Bijan Fouladi United States
Paul S. Bradshaw Canada
Ruben C. Petreaca United States
Rachel B. Cervantes United States
Katherine T. Etheridge United States
Oleksandr Dergai Ukraine
Jaewon Min United States
Kalliopi Stratigi Greece
Katja Kratz Switzerland
Judit Pampalona Spain
Barbara Zellinger
Citations per year, relative to Barbara Zellinger Barbara Zellinger (= 1×) peers Judit Pampalona

Countries citing papers authored by Barbara Zellinger

Since Specialization
Citations

This map shows the geographic impact of Barbara Zellinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Zellinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Zellinger more than expected).

Fields of papers citing papers by Barbara Zellinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Zellinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Zellinger. The network helps show where Barbara Zellinger may publish in the future.

Co-authorship network of co-authors of Barbara Zellinger

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Zellinger. A scholar is included among the top collaborators of Barbara Zellinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Zellinger. Barbara Zellinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
Beheshti, Mohsen, J. Karner, Barbara Zellinger, et al.. (2023). Pretreatment 18-FDG-PET/CT parameters can serve as prognostic imaging biomarkers in recurrent NSCLC patients treated with reirradiation-chemoimmunotherapy. Radiotherapy and Oncology. 185. 109728–109728. 6 indexed citations
3.
Karner, J., Barbara Zellinger, Michael Studnicka, et al.. (2023). Chemo-Radio-Immunotherapy for NSCLC III: ESR/ATS Thresholds for DLCO Correlate with Radiation Dosimetry and Pneumonitis Rate. Cancers. 15(7). 1966–1966. 3 indexed citations
4.
5.
Kaiser, Bernhard, J. Karner, S. Gerum, et al.. (2022). High Dose Thoracic Re-Irradiation and Chemo-Immunotherapy for Centrally Recurrent NSCLC. Cancers. 14(3). 573–573. 6 indexed citations
6.
Karner, J., Barbara Zellinger, Michael Studnicka, et al.. (2022). Carbon Monoxide Diffusing Capacity (DLCO) Correlates with CT Morphology after Chemo-Radio-Immunotherapy for Non-Small Cell Lung Cancer Stage III. Diagnostics. 12(5). 1027–1027. 4 indexed citations
7.
8.
Zellinger, Barbara, Ulrich Bodenhofer, J. Karner, et al.. (2021). Hsa-miR-3651 could serve as a novel predictor for in-breast recurrence via FRMD3. Breast Cancer. 29(2). 274–286. 5 indexed citations
9.
Hutarew, Georg, Barbara Zellinger, Christoph Schwartz, et al.. (2021). Integrated analysis of programmed cell death ligand 1 expression reveals increased levels in high-grade glioma. Journal of Cancer Research and Clinical Oncology. 147(8). 2271–2280. 14 indexed citations
10.
Kraus, Theo F. J., et al.. (2021). Genotypical glioblastoma of the frontal lobe mimicking ganglioglioma: A case report and review of the literature. SHILAP Revista de lepidopterología. 9(9). e04544–e04544. 1 indexed citations
11.
Kraus, Theo F. J., Barbara Zellinger, Christoph Schwartz, et al.. (2020). Diffuse midline glioma of the cervical spinal cord with H3 K27M genotype phenotypically mimicking anaplastic ganglioglioma: a case report and review of the literature. Brain Tumor Pathology. 37(3). 89–94. 13 indexed citations
12.
Zellinger, Barbara, Ulrich Bodenhofer, Peter Strasser, et al.. (2020). Hsa-miR-375/RASD1 Signaling May Predict Local Control in Early Breast Cancer. Genes. 11(12). 1404–1404. 10 indexed citations
13.
Rendl, Gundula, Margarida Rodrigues, A Hittmair, et al.. (2017). Clinicopathological characteristics of thyroid cancer in the federal state of Salzburg. Wiener klinische Wochenschrift. 129(15-16). 540–544. 4 indexed citations
14.
Zehentmayr, Franz, Cornelia Hauser‐Kronberger, Barbara Zellinger, et al.. (2016). Hsa-miR-375 is a predictor of local control in early stage breast cancer. Clinical Epigenetics. 8(1). 28–28. 45 indexed citations
15.
Zellinger, Barbara, et al.. (2012). Chromosome end protection by blunt-ended telomeres. Genes & Development. 26(15). 1703–1713. 58 indexed citations
16.
Akimcheva, Svetlana, et al.. (2008). Genome stability in <i>Arabidopsis</i> cells exhibiting alternative lengthening of telomeres. Cytogenetic and Genome Research. 122(3-4). 388–395. 10 indexed citations
17.
Zellinger, Barbara & Karel Říha. (2007). Composition of plant telomeres. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1769(5-6). 399–409. 41 indexed citations
18.
Zellinger, Barbara, et al.. (2007). Ku Suppresses Formation of Telomeric Circles and Alternative Telomere Lengthening in Arabidopsis. Molecular Cell. 27(1). 163–169. 93 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Judit Pampalona Breakdown of academic impact, for papers by Bijan Fouladi Breakdown of academic impact, for papers by Paul S. Bradshaw Breakdown of academic impact, for papers by Ruben C. Petreaca Breakdown of academic impact, for papers by Rachel B. Cervantes Breakdown of academic impact, for papers by Katherine T. Etheridge Breakdown of academic impact, for papers by Oleksandr Dergai Breakdown of academic impact, for papers by Jaewon Min Breakdown of academic impact, for papers by Kalliopi Stratigi Breakdown of academic impact, for papers by Katja Kratz
Rankless by CCL
2026